Our Parkinson's Place: Medtronic earns CE mark for deep brain stimulation software

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

Friday, August 12, 2016

Medtronic earns CE mark for deep brain stimulation software

by Alyssa Huntley

Aug 9, 2016

Medtronic ($MDT) has earned a CE mark for its SureTune2 software. The tech offers physicians patient-specific visualizations which help them to “tune” a patient’s deep brain stimulation (DBS) therapy.

DBS therapy is a targeted treatment that offers specific symptom control through mild electrical stimulation in the brain. “The brain targets are stimulated through lead(s) inserted into the brain and connected to an implantable neurostimulator through extensions running under the skin,” Medtronic explained in the announcement. “A medical professional uses an external programmer to set and adjust stimulation settings.”

Having to manually program settings can be a time-consuming process. Medtronic’s SureTune2 aims to alleviate some of the frustrations of this process. Using visualization of patient-specific information, SureTune2 works along with Medtronic DBS therapy and other DBS therapy systems to select the best stimulation settings for a patient.

The visualizations offer up a comprehensive view which includes anatomy, physiology and calculated stimulation field. Using a greyscale threshold within a region of interest, users can segment structures.

"[SureTune2] simplifies the trial and error process associated with DBS programming by helping me identify the best contacts, which saves me time,” said Jens Volkmann, chairman and professor of neurology at the University Clinic of Würzburg.

Lothar Krinke, the vice president and general manager of the brain modulation business in Medtronic’s Restorative Therapies Group, noted in the announcement that SureTune shows how committed Medtronic is to “providing integrated solutions for improving accuracy and confidence from surgery to post-operative DBS patient management."

Medtronic’s DBS therapy has been used by over 140,000 patients worldwide to help with disabling symptoms of essential tremor, Parkinson’s disease and dystonia. While Medtronic’s DBS therapy system is approved in many locations throughout the world, SureTune2 is not yet approved in the United States.

http://www.fiercebiotech.com/medical-devices/medtronic-earns-ce-mark-for-deep-brain-stimulation-software